HSIC

70.47

2.67% 1.83

Dopo l'orario di chiusura: 70.47

Henry Schein Inc (HSIC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$68.64

Aprire:

$70.32

Volume 24 ore:

1.56M

Relative Volume:

0.87

Capitalizzazione di mercato:

$8.10B

Reddito:

$12.50B

Utile/perdita netta:

$314.00M

Rapporto P/E:

28.88

EPS:

2.44

Flusso di cassa netto:

$421.00M

1 W Prestazione:

+5.84%

1M Prestazione:

+9.32%

6M Prestazione:

+4.46%

1 anno Prestazione:

-3.87%

Intervallo 1D:

$69.51

$71.33

Intervallo di 1 settimana:

$65.86

$71.33

Portata 52W:

$60.56

$82.49

Henry Schein Inc Stock (HSIC) Company Profile

Nome

Henry Schein Inc

Settore

Healthcare (1154)

Industria

Medical Distribution (13)

Telefono

(631) 843-5500

Indirizzo

135 DURYEA RD, MELVILLE, NY

Dipendente

25,000

Cinguettio

@henryschein

Prossima data di guadagno

2024-11-05

Ultimi documenti SEC

HSIC's Discussions on Twitter

Confronta HSIC con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HSIC Henry Schein Inc	70.47	8.10B	12.50B	314.00M	421.00M	2.44
MCK Mckesson Corporation	687.52	88.38B	359.05B	3.30B	5.23B	25.83
COR Cencora Inc	278.38	56.56B	310.23B	1.69B	3.58B	8.62
CAH Cardinal Health Inc	148.62	36.28B	222.29B	1.56B	2.44B	6.41
OMI Owens Minor Inc	7.15	626.70M	10.42B	-38.77M	323.54M	-0.51

Henry Schein Inc Stock (HSIC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-02-14	Iniziato	Wells Fargo	Equal Weight
2025-01-06	Aggiornamento	BofA Securities	Underperform → Buy
2024-12-04	Iniziato	Mizuho	Neutral
2024-07-22	Aggiornamento	Robert W. Baird	Neutral → Outperform
2024-02-26	Iniziato	Leerink Partners	Market Perform
2023-12-12	Aggiornamento	JP Morgan	Neutral → Overweight
2023-11-10	Aggiornamento	Stifel	Hold → Buy
2022-08-08	Aggiornamento	UBS	Sell → Neutral
2022-07-21	Downgrade	Goldman	Buy → Neutral
2022-06-14	Downgrade	Robert W. Baird	Outperform → Neutral
2022-05-13	Ripresa	Credit Suisse	Outperform
2022-01-31	Iniziato	Morgan Stanley	Underweight
2022-01-07	Aggiornamento	Credit Suisse	Neutral → Outperform
2021-10-01	Ripresa	Credit Suisse	Neutral
2021-02-08	Ripresa	Piper Sandler	Overweight
2021-01-04	Aggiornamento	Robert W. Baird	Neutral → Outperform
2020-11-03	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2020-05-06	Downgrade	Barrington Research	Outperform → Mkt Perform
2020-04-07	Aggiornamento	Goldman	Neutral → Buy
2020-04-02	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2020-01-09	Downgrade	BofA/Merrill	Neutral → Underperform
2020-01-02	Aggiornamento	Evercore ISI	Underperform → In-line
2019-08-07	Downgrade	William Blair	Outperform → Mkt Perform
2019-05-30	Iniziato	Wolfe Research	Underperform
2019-05-15	Downgrade	SVB Leerink	Outperform → Mkt Perform
2019-04-18	Iniziato	Guggenheim	Buy
2019-01-17	Iniziato	UBS	Sell
2019-01-03	Downgrade	Evercore ISI	In-line → Underperform
2019-01-02	Downgrade	Robert W. Baird	Outperform → Neutral
2018-11-08	Reiterato	Barrington Research	Outperform
2018-10-25	Downgrade	Edward Jones	Hold → Sell
2018-10-19	Ripresa	Goldman	Neutral
2018-10-04	Reiterato	Robert W. Baird	Outperform
2018-08-07	Reiterato	Stifel	Hold
2018-04-24	Downgrade	Goldman	Buy → Neutral
2018-04-04	Aggiornamento	Leerink Partners	Mkt Perform → Outperform

Mostra tutto

Henry Schein Inc Borsa (HSIC) Ultime notizie

May 12, 2025

Henry Schein's (NASDAQ:HSIC) Strong Earnings Are Of Good Quality - Yahoo Finance

May 12, 2025

May 11, 2025

Henry Schein outlines 2025 growth targets amid strategic restructuring and stable market conditions - MSN

May 11, 2025

May 08, 2025

Henry Schein misses quarterly revenue estimates on weak demand for dental products - MSN

May 08, 2025

May 07, 2025

Henry Schein First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

May 07, 2025

Dental Consumables Market Projected to Hit USD 70.55 Billion by 2032 Amid Rising Demand for Aesthetic and Restorative Dental Care – SNS Insider - GlobeNewswire Inc.

May 07, 2025

May 06, 2025

Henry Schein (HSIC) Maintains 'Outperform' Rating Despite Price Target Adjustment | HSIC Stock News - GuruFocus

May 06, 2025

Henry Schein Schedules May Investor Presentations - Dentistry Today

May 06, 2025

Barrington Research Adjusts Henry Schein Price Target to $86 From $90, Maintains Outperform Rating - marketscreener.com

May 06, 2025

Henry Schein (HSIC) Price Target Lowered by Wells Fargo Analyst - GuruFocus

May 06, 2025

Henry Schein (HSIC) Price Target Lowered by Wells Fargo Analyst | HSIC Stock News - GuruFocus

May 06, 2025

What 6 Analyst Ratings Have To Say About Henry Schein - Benzinga

May 06, 2025

These Analysts Lower Their Forecasts On Henry Schein Following Q1 Results - Benzinga

May 06, 2025

Henry Schein (HSIC) Sees Price Target Cut Despite Strong Q1 Repo - GuruFocus

May 06, 2025

Henry Schein, Inc. (NASDAQ:HSIC) Q1 2025 Earnings Call Transcript - Insider Monkey

May 06, 2025

Henry Schein Positioned for Growth: Buy Rating Reaffirmed Amid Strategic Expansion and Board Expertise - TipRanks

May 06, 2025

Henry Schein (HSIC) Sees Price Target Cut Despite Strong Q1 Report | HSIC Stock News - GuruFocus

May 06, 2025

Henry Schein to Participate in Upcoming Investor Conferences in May | HSIC Stock News - GuruFocus

May 06, 2025

Wells Fargo Adjusts Price Target for Henry Schein (HSIC) | HSIC Stock News - GuruFocus

May 06, 2025

Henry Schein Reports First Quarter 2025 Financial Results - Zenopa

May 06, 2025

Henry Schein to Participate in Upcoming Investor Conferences in May 2025 - BioSpace

May 06, 2025

Henry Schein Sets Bank of America and Stifel Conference Appearances: Key Dates for Healthcare Investors - Stock Titan

May 06, 2025

Henry Schein to Participate in Upcoming Investor Conferences in May - Bluefield Daily Telegraph

May 06, 2025